HSP90AB1 and cancer: Several oncoproteins are inactivated and destabilized simultaneously in cancer cells treated with Hsp90 drugs, potentially allowing a combinatorial depletion of many cancer-causing pathways and a modulation of all of the hallmark traits of malignancy [4,5].